Life Sciences IP Focus 2012

  • Editorial

  • Interview: Robert Armitage, Eli Lilly

    The American Invents Act could have a big effect on the life sciences industry. Kevin Matha spoke with Robert A Armitage, senior vice president and general counsel at Eli Lilly, about the new legislative package

  • Interview: Looking back on decades of industry change

    Tom Ciotti and Kate Murashige of Morrison & Foerster have been involved with the life sciences industry for almost 50 years. Phillip Bausk spoke with them about the changes they have seen in that time

  • Europe: Patenting plant breeding

    Edward J Farrington of Inspicos considers the role of human intervention when acertaining the limits of patentability in plant breeding

  • Europe: Selection inventions

    Louise Tottie and Anette Romare of Valea outline important aspects of selection inventions relating to lists and ranges, to consider when drafting patent applications

  • Mexico: New practice on medical-use claims

    Agustín Azcatl, Daniel Sánchez and Pedro Herrera of Olivares & Cia explain the impact of rule changes on first medical-use claims

  • US: The America Invents Act

    Ha Kung Wong and John Kirkland of Fitzpatrick Cella Harper & Scinto use three scenarios to examine the impact of the Act and the future of paragraph IV litigation


More from the Managing IP blog


April 2014

India's trade mark office goes digital

India’s legal system, including its trade mark registry, has long been criticised for long pendency times and a morass of bureaucratic obstacles. However, a recent push toward digitisation has brought much-welcomed efficiency gains. Peter Leung reports



Most read articles

Supplements